Structure, function and pathophysiology of protease activated receptors
- PMID: 21277892
- DOI: 10.1016/j.pharmthera.2011.01.003
Structure, function and pathophysiology of protease activated receptors
Abstract
Discovered in the 1990s, protease activated receptors(1) (PARs) are membrane-spanning cell surface proteins that belong to the G protein coupled receptor (GPCR) family. A defining feature of these receptors is their irreversible activation by proteases; mainly serine. Proteolytic agonists remove the PAR extracellular amino terminal pro-domain to expose a new amino terminus, or tethered ligand, that binds intramolecularly to induce intracellular signal transduction via a number of molecular pathways that regulate a variety of cellular responses. By these mechanisms PARs function as cell surface sensors of extracellular and cell surface associated proteases, contributing extensively to regulation of homeostasis, as well as to dysfunctional responses required for progression of a number of diseases. This review examines common and distinguishing structural features of PARs, mechanisms of receptor activation, trafficking and signal termination, and discusses the physiological and pathological roles of these receptors and emerging approaches for modulating PAR-mediated signaling in disease.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Protease activated receptors in cardiovascular function and disease.Mol Cell Biochem. 2004 Aug;263(1-2):227-39. Mol Cell Biochem. 2004. PMID: 15524183 Review.
-
Protease-activated receptors: contribution to physiology and disease.Physiol Rev. 2004 Apr;84(2):579-621. doi: 10.1152/physrev.00028.2003. Physiol Rev. 2004. PMID: 15044683 Review.
-
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.J Cell Sci. 2007 Mar 15;120(Pt 6):921-8. doi: 10.1242/jcs.03409. J Cell Sci. 2007. PMID: 17344429 Review.
-
Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.Neuroscientist. 2004 Dec;10(6):501-12. doi: 10.1177/1073858404269955. Neuroscientist. 2004. PMID: 15534036 Review.
-
Protease-activated receptors: protease signaling in the gastrointestinal tract.Curr Opin Pharmacol. 2004 Dec;4(6):551-6. doi: 10.1016/j.coph.2004.08.004. Curr Opin Pharmacol. 2004. PMID: 15525542 Review.
Cited by
-
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Neuro Oncol. 2013 Mar;15(3):305-18. doi: 10.1093/neuonc/nos313. Epub 2013 Jan 10. Neuro Oncol. 2013. PMID: 23307575 Free PMC article.
-
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.Br J Pharmacol. 2015 Sep;172(18):4535-4545. doi: 10.1111/bph.13238. Epub 2015 Aug 3. Br J Pharmacol. 2015. PMID: 26140338 Free PMC article.
-
Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage.PLoS One. 2013 Sep 19;8(9):e75708. doi: 10.1371/journal.pone.0075708. eCollection 2013. PLoS One. 2013. PMID: 24069438 Free PMC article.
-
Identifying and quantifying two ligand-binding sites while imaging native human membrane receptors by AFM.Nat Commun. 2015 Nov 12;6:8857. doi: 10.1038/ncomms9857. Nat Commun. 2015. PMID: 26561004 Free PMC article.
-
CALCB splice region pathogenic variants leading to plasma cell neurotropic enrichment in type 1 autoimmune pancreatitis.Cell Death Dis. 2017 Feb 2;8(2):e2591. doi: 10.1038/cddis.2017.32. Cell Death Dis. 2017. PMID: 28151472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous